MCAT and prostate carcinoma: In accordance, the staining levels of NDUFS4 (p = 0.01), SDHA (p < 0.0001), UQCRC2 (p < 0.05), MT-CO1 (p < 0.05), and ATP5F1A (p < 0.0001) were all significantly higher in the prostate carcinomas compared to their benign counterparts (Figures 2(b)–2(f)).